Skip to main content
Springer logoLink to Springer
. 2019 Apr 29;79(7):795. doi: 10.1007/s40265-019-01122-z

Correction to: Sarecycline: First Global Approval

Emma D Deeks 1,
PMCID: PMC6520308  PMID: 31037601

Correction to: Drugs (2019) 79:325–329 10.1007/s40265-019-1053-4

The article Sarecycline: First Global Approval, written by Emma D. Deeks, was originally published Online First without open access. After publication in volume 79, issue 3, pages 325–329 Almirall, LLC., requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Almirall, LLC. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. Additional information for this AdisInsight Report has also been added and can be found at 10.6084/m9.figshare.8029316.

The original article has been corrected.


Articles from Drugs are provided here courtesy of Springer

RESOURCES